- Details
- Hits: 1583
First published:20 February 2020
Abstract - Findings: the initiation of recreational cannabis commercialization was associated with 5.06–5.80 more exposures per 1 000 000 population per quarter (67–77% increase relative to the pre‐legalization average), depending on the composition of comparison states. The increase associated with commercialization was higher among minors than adults (7.97–9.53 versus 3.83–4.21 more exposures), higher among males than females (6.16–7.56 versus 3.76–3.91 more exposures) and higher among exposures with medical consequences than those without medical consequences (4.09–4.79 versus 0.97–1.01 more exposures).
Conclusion: An increase in cannabis exposures reported to the US National Poison Data System was observed following recreational cannabis commercialization in the United States.
- Details
- Hits: 1612
- The study finds that marijuana commercialization was associated with a 67-77% increase in marijuana exposure calls to poison control centers, with a dramatic rise in exposures among those below the age of 21.
- According to the study, had all 50 states and DC commercialized marijuana in 2017, the total number of exposures nationwide would have risen by more than 60%.
- Also according to the study, marijuana commercialization increased the availability and accessibility of marijuana among minors.
- Details
- Hits: 1815
- Details
- Hits: 1809
Guillermo, a 19-year-old Chicagoan, said the first time he got stoned “felt like I was a piece of butter melting on a stack of pancakes.” But the rapture faded quickly, and smoking weed soon became a joyless reflex akin to brushing his teeth in the morning, he said.
Potent marijuana frequently put him into hangoverlike “kush comas,” he said, and sapped his motivation and alertness so thoroughly that his mother threatened to put him into a mental hospital.
“I was just stoned all the time,” he said. “I was barely even there.”